{{Drugbox
| verifiedrevid = 443935395
| IUPAC_name = (3β,5β,12β)-3-{[2,6-dideoxy-4-''O''-methyl-β-<small>D</small>-''ribo''-hexopyranosyl-(1&rarr;4)-2,6-dideoxy-β-<small>D</small>-''ribo''-hexopyranosyl-(1&rarr;4)-2,6-dideoxy-β-<small>D</small>-''ribo''-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide
| image = medigoxin.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|medigoxin}}
| pregnancy_category = C
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =

<!--Identifiers-->
| CAS_number = 30685-43-9
| ATC_prefix = C01
| ATC_suffix = AA08
| PubChem = 443946
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 392000
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = I7GG1YUC5V

<!--Chemical data-->
| C=42 | H=66 | O=14 
| molecular_weight = 794.965
| smiles = O=C\1OC/C(=C/1)[C@H]2CC[C@@]8(O)[C@]2(C)[C@H](O)C[C@H]7[C@H]8CC[C@H]6[C@]7(C)CC[C@H](O[C@@H]5O[C@H](C)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@@H]3O[C@@H]([C@@H](OC)[C@@H](O)C3)C)[C@@H](O)C4)C)[C@@H](O)C5)C6
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C42H66O14/c1-20-37(49-6)29(43)16-35(51-20)55-39-22(3)53-36(18-31(39)45)56-38-21(2)52-34(17-30(38)44)54-25-9-11-40(4)24(14-25)7-8-27-28(40)15-32(46)41(5)26(10-12-42(27,41)48)23-13-33(47)50-19-23/h13,20-22,24-32,34-39,43-46,48H,7-12,14-19H2,1-6H3/t20-,21-,22-,24-,25+,26-,27-,28+,29+,30+,31+,32-,34+,35+,36+,37-,38-,39-,40+,41+,42+/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = IYJMSDVSVHDVGT-PEQKVOOWSA-N
| synonyms = <small>4-[(''3S,5R,8R,9S,10S,12R,13S,14S'')-12,14-Dihydroxy-3-[(''2R,4S,5S,6R'')-4-hydroxy-5-[(''2S,4S,5S,6R'')-4-hydroxy-5-[(''2S,4S,5S,6R'')-4-hydroxy-5-methoxy-6-methyl-oxan-2-yl]oxy-6-methyl-oxan-2-yl]oxy-6-methyl-oxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[''a'']phenanthren-17-yl]-''5H''-furan-2-one</small>
}}

'''Metildigoxin''' ([[International Nonproprietary Name|INN]], or '''medigoxin''' [[British Approved Name|BAN]], or '''methyldigoxin''') is a [[cardiac glycoside]],<ref>{{Cite journal 
| last1 = Hayward | first1 = R. 
| last2 = Greenwood | first2 = H. 
| last3 = Stephens | first3 = J. 
| last4 = Hamer | first4 = J. 
| title = Relationship between myocardial uptake and actions in heart failure of methyldigoxin 
| journal = British Journal of Clinical Pharmacology 
| volume = 15 
| issue = 1 
| pages = 41–48 
| year = 1983 
| pmid = 6849743 
| pmc = 1427830 | doi=10.1111/j.1365-2125.1983.tb01461.x
}}</ref> a type of drug that can be used in the treatment of [[congestive heart failure]] and [[cardiac arrhythmia]] (irregular heartbeat). The substance is closely related to [[digoxin]]; it differs from the latter only by an O-[[methyl]] group on the terminal [[monosaccharide]].

==References==
{{reflist}}

{{Cardiac glycosides}}

[[Category:Antiarrhythmic agents]]
[[Category:Cardenolides]]


{{cardiovascular-drug-stub}}